Huapont Life Sciences Co.,Ltd financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥272.53M ¥273.21M ¥287.32M ¥492.37M ¥575.72M ¥544.52M ¥541.22M ¥638.10M ¥3.88B ¥4.47B ¥4.87B ¥6.17B ¥7.09B ¥9.18B ¥10.57B ¥10.09B ¥10.88B ¥12.43B ¥13.23B ¥0.00M ¥0.00M
GM % Gross Margin %
76.31% 76.98% 77.50% 62.88% 64.71% 62.77% 66.33% 65.91% 25.23% 26.01% 30.18% 34.40% 32.27% 31.47% 39.98% 45.98% 40.52% 37.58% 39.76% 0.00% 0.00%
OM Operating Margin
21.71% 22.08% 21.98% 16.24% 14.58% 16.93% 19.48% 17.79% 10.29% 10.23% 11.44% 13.20% 10.88% 9.26% 13.17% 14.99% 13.59% 11.94% 14.17% 0.00% 0.00%
EPS Earnings Per Share
¥0.05 ¥0.13 ¥0.12 ¥0.12 ¥0.19 ¥0.21 ¥0.26 ¥0.34 ¥0.27 ¥0.27 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.12 ¥0.00 ¥0.12 ¥0.20 ¥0.15 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.00 ¥0.15 ¥0.00
PR % Payout Ratio %
0 0 0.00% 0 0 0 0 0 63.16% 0.00% 46.15% 58.82% 55.56% 0 0 0 0 0 0 55.56% 0
Sha. Shares
990m 990m 990m 990m 990m 990m 990m 1256.2m 1256.2m 1451.83m 1689.15m 2034.88m 2034.83m 2034.83m 2001.96m 1979.92m 1979.92m 1979.92m 1979.92m 0m 1979.92m
OCF Operating Cash Flow
¥70.60M ¥0.00M ¥66.10M ¥79.21M ¥85.16M ¥123.53M ¥79.84M ¥135.23M ¥257.75M ¥350.19M ¥455.96M ¥342.45M ¥511.90M ¥627.71M ¥1.91B ¥2.08B ¥2.37B ¥1.27B ¥2.41B ¥0.00M ¥0.00M
FCF Free Cash Flow
¥43.77M ¥0.00M ¥18.34M ¥-44.81M ¥-7.33M ¥49.57M ¥22.97M ¥39.46M ¥-57.46M ¥-29.62M ¥-129.58M ¥-477.19M ¥-139.34M ¥-405.22M ¥809.07M ¥648.66M ¥1.14B ¥13.19M ¥1.28B ¥0.00M ¥0.00M
FCFS Free Cash Flow Per Share
¥0.00 ¥0.00 ¥0.02 ¥-0.05 ¥-0.01 ¥0.05 ¥0.02 ¥0.04 ¥-0.05 ¥-0.02 ¥-0.08 ¥-0.26 ¥-0.07 ¥-0.20 ¥0.40 ¥0.32 ¥0.58 ¥0.01 ¥0.64 ¥0.00 ¥0.00